Fabrice Pothier
{
"authors": [
"Fabrice Pothier"
],
"type": "legacyinthemedia",
"centerAffiliationAll": "dc",
"centers": [
"Carnegie Endowment for International Peace",
"Carnegie Europe"
],
"collections": [
"Transatlantic Cooperation",
"Brexit and UK Politics"
],
"englishNewsletterAll": "ctw",
"nonEnglishNewsletterAll": "",
"primaryCenter": "Carnegie Europe",
"programAffiliation": "SAP",
"programs": [
"South Asia"
],
"projects": [],
"regions": [
"Asia",
"Europe",
"North America",
"Afghanistan",
"Pakistan"
],
"topics": [
"Foreign Policy",
"Economy"
]
}Source: Getty
NATO's Drug Problem
NATO's new war on drugs in Afghanistan will put troops in greater danger for a venture that may not even work. It just might be the straw that breaks the alliance's back.
Source: The National Interest

Advocates presented this decision as a “tactical adjustment.” But in fact it marks an attempt to militarize our way out of the narcotics problem in Afghanistan. At a time when troops on the ground are stretched thin and the coalition is losing the battle for Afghan hearts and minds, such a radical shift in policy could prove to be NATO's mission-too-far.
No foreign army has ever succeeded in a counternarcotics effort of this kind. Drugs are fundamentally economic and law enforcement issues. At best, military force has made only a marginal impact, and in most cases, it has been counterproductive. Thailand, Burma and, to a lesser extent, Colombia succeeded in eliminating or gaining partial control of their drug trades only after decades of sustained political and economic development efforts. But Thailand, for one, had to offer its farmers a five-year amnesty to switch from illegal to legitimate crops.
(To continue reading, click here)
About the Author
Former Director, Carnegie Europe
Pothier, director of Carnegie Europe, is a noted commentator on European policy in Afghanistan and Pakistan, transatlantic issues, and global drug policy.
- Can Macron Reload the Minsk Process?Commentary
- Where's Europe?Q&A
Fabrice Pothier
Recent Work
Carnegie India does not take institutional positions on public policy issues; the views represented herein are those of the author(s) and do not necessarily reflect the views of Carnegie, its staff, or its trustees.
More Work from Carnegie India
- India’s Press Note 3 Gamble: Opening the FDI Door to ChinaArticle
On March 10, 2026, India’s Union Cabinet approved amendments to Press Note 3, a regulation that mandated government approval on all foreign direct investment (FDI) from countries sharing a land border with India. This amendment raises questions primarily about whether its stated benefits will materialize and if the risks have been adequately weighed. This piece will address the same.
Konark Bhandari
- The Impact of U.S. Sanctions and Tariffs on India’s Russian Oil ImportsCommentary
This piece examines India’s response to U.S. sanctions and tariffs, specifically assessing the immediate market consequences, such as alterations in import costs, and the broader strategic implications for India’s energy security and foreign policy orientation.
Vrinda Sahai
- India-China Economic Ties: Determinants and PossibilitiesPaper
This paper examines the evolution of India-China economic ties from 2005 to 2025. It explores the impact of global events, bilateral political ties, and domestic policies on distinct spheres of the economic relationship.
Santosh Pai
- NISAR Soars While India-U.S. Tariff Tensions SimmerCommentary
On July 30, 2025, the United States announced 25 percent tariffs on Indian goods. While diplomatic tensions simmered on the trade front, a cosmic calm prevailed at the Sriharikota launch range. Officials from NASA and ISRO were preparing to launch an engineering marvel into space—the NASA-ISRO Synthetic Aperture Radar (NISAR), marking a significant milestone in the India-U.S. bilateral partnership.
Tejas Bharadwaj
- TRUST and TariffsCommentary
The India-U.S. relationship currently appears buffeted between three “Ts”—TRUST, Tariffs, and Trump.
Arun K. Singh